92 low- and middle-income economies eligible to get access to COVID-19 vaccines through Gavi COVAX AMC

Geneva, 31 July 2020 – A total of 92 low- and middle-income countries and economies will be able to access COVID-19 vaccines through Gavi’s COVAX Advance Market Commitment (AMC), the Gavi Board agreed yesterday. The Board also agreed that the Gavi secretariat will host and administer the COVAX Facility, the umbrella mechanism to which 78 countries have already submitted written expressions of interest.

Read more here.

You May Also Like

Research Funding Opportunity: Health policy and systems research for vaccine uptake in low- and middle-income countries – deadline 24 July 2024

The Alliance for Health Policy and Systems Research (the Alliance) is seeking expressions of interest (EoIs) from research and policy teams based in select low- and middle-income countries (LMICs) to use health policy and systems research to respond to identified national priorities related to improving vaccine uptake. EoIs can focus on one of two tracks: … Read More

Linked Community News June 2024

This newsletter is available in English, Portuguese, Spanish, and Russian. We’re kicking off June with exciting network updates and the latest evidence from the global immunisation community. At the end of May, Linked held a two-day kickoff meeting in Jakarta for the new Indonesia Subnational Peer-to-Peer Learning Platform. Immunisation practitioners, policymakers, and partners working at … Read More

Immunization Delivery Cost Catalogue update: The state of the evidence on the cost of delivering immunisation in low- and middle-income countries

ThinkWell is pleased to present an updated version of the Immunization Delivery Cost Catalogue, or IDCC, the most comprehensive, current, and standardized database on the cost of delivering vaccines in low- and middle-income countries. Based on a systematic review of over 22,000 publications, the updated IDCC presents 1,156 unique unit costs from 119 publications, in … Read More